This site uses cookies. By using this site you agree to receiving cookies. View Policy.

Inspira Pharma is developing a potential new therapy for COVID-19. The active molecules being tested are plant-based and have shown an ability to destroy the SARS-CoV-2 virus in the lab. Funds raised will be used to test clinical formulations and prove safety and efficacy in humans.

  • Amount raised (£)

    £383,417.70

  • Company number

    13045376

  • Incorporation date

    26/11/2020

  • Total investors

    756

Details

  • Company number

    13045376

  • Incorporation date

    26/11/2020

  • Company status

    Active

  • Industry type

    Wholesale of pharmaceutical goods

  • Number of current appointments

    2

130 Old Street
London
EC1V 9BD

Crowdcube Funding History

Date Amount No. of Investors
15/05/2021 £383,417.70 756 View
Date Description Type
05/05/2021

Sub-division of shares on 2021-04-07

PDF
04/05/2021

Statement of capital following an allotment of shares on 2021-04-06

PDF
16/04/2021

Confirmation statement made on 2021-04-16 with updates

PDF

People

Name Role Appointed Nationality
MCGOLDRICK, Rory James Director 21/01/2021 Australian
WOOLF, Nicholas Leslie Director 20/11/2020 British